Metabolism
|
OPPORTUNITY NUMBER |
OPPORTUNITY TITLE |
AGENCY NAME |
POSTED DATE |
CLOSE DATE |
|---|---|---|---|---|
|
Toward ElucidAting MechanismS Contributing to HIV Reservoirs in NIDDK-relevant Tissues (Cure TEAMS) (R01 Clinical Trial Optional) |
HHS-NIH11 |
09/01/2020 |
11/17/2021 |
|
|
Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional) |
HHS-NIH11 |
08/24/2020 |
11/17/2021 |
|
|
Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones (R21/R33 Clinical Trial Required) |
NIH |
03/11/2020 |
06/08/2021 |
|
|
Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed) |
NIH |
06/06/2019 |
11/12/2021 |
|
|
Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed) |
NIH |
04/26/2019 |
12/13/2021 |
|
|
Drug Discovery For Nervous System Disorders (R21 Clinical Trial Not Allowed) |
NIH |
01/08/2019 |
01/07/2022 |
|
|
Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) |
NIH |
01/08/2019 |
01/07/2022 |
|
|
Elucidating the Role of the Autonomic Nervous System in Peripheral Metabolism and Metabolic Disease through the Application of Novel Tools and Methodologies (RC2 Clinical Trial Optional) |
NIH |
8/9/2018 |
6/1/2021 |
|
|
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional) |
NIH |
8/7/2018 |
9/7/2021 |
|
|
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional) |
NIH |
8/7/2018 |
9/7/2021 |
|
|
Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R01 - Clinical Trial Optional) |
NIH |
6/26/2018 |
9/7/2021 |
|
|
Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R21 Clinical Trial Optional) |
NIH |
6/26/2018 |
9/7/2021 |
|
|
Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical Trial Not Allowed) |
NIH |
4/3/2018 |
5/7/2021 |